Name: Collegium Pharmaceutical, Inc. (COLL) Financial Statements
Creator: FinSpry

Collegium Pharmaceutical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Collegium Pharmaceutical, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	631.45	566.77	463.93	276.87	310.02	296.70	280.41
Cost of Revenue	254.11	79.72	254.45	126.25	69.50	193.66	165.68
Gross Profit	377.34	487.05	209.49	150.62	240.52	103.04	114.74
Operating Expenses
Research & Development	0.00	0.00	3.98	9.45	9.77	10.34	8.66
Selling, General & Administrative	182.98	150.71	172.19	118.96	113.83	116.45	126.76
Operating Expenses	207.45	296.47	176.17	128.41	184.28	126.79	135.42
Operating Income	169.90	190.58	33.32	22.21	56.23	-23.75	-20.69
Other Income/Expense
Interest Income	13.98	15.62	1.05	0.01	0.23	0.00	1.69
Interest Expense	73.97	-83.34	-63.21	21.01	-28.88	0.00	20.13
Other Income/Expense	-71.33	-23.50	-1.05	-4.58	-0.23	-1.94	0.00
Income
Income Before Tax	98.57	75.73	-28.85	-3.37	27.58	-22.72	-39.13
Income Tax Expense	29.38	27.58	-3.85	-74.89	0.83	0.00	0.00
Net Income	69.19	48.16	-25.00	71.52	26.75	-22.72	-39.13
Net Income - Continuous Operations	69.19	48.16	-25.00	71.52	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	341.70	339.83	173.31	86.56	117.78	-6.33	91.91
EBIT	98.57	190.58	34.37	17.64	56.23	-21.81	-19.00
Depreciation & Amortization	169.16	149.26	2.68	68.92	61.55	0.73	0.00
Earnings Per Share
Basic EPS	2.00	1.00	-1.00	2.00	1.00	-1.00	-1.00
Diluted EPS	2.00	1.00	-1.00	2.00	1.00	-1.00	-1.00
Basic Shares Outstanding	32.27	33.74	33.83	34.94	34.41	33.45	32.95
Diluted Shares Outstanding	40.42	41.79	33.83	41.05	35.15	0.00	32.95